Figure 1.
Patient control category distributions relative to AIRQ cross-sectional validation standards. a48% of patients who shifted to well-controlled went on to have ≥ 1 subsequent-year exacerbation. The change in asthma control status as noted by validation standard (ACT+ exacerbations vs ACT Alone). The shift in control groups is reflected from left to right in the figure. N = 437 for patients with baseline AIRQ and ACT, whereas n = 428 for patients with 1-year follow-up data.